
Am J Psychiatry 157:1006-1008, June 2000
© 2000 American Psychiatric Association
Platelet Activation in Depression and Effects of Sertraline Treatment: An Open-Label Study
Jerome H. Markovitz, M.D., M.P.H.,
John L. Shuster, M.D.,,
William S. Chitwood, M.D.,
Roberta S. May, M.A., and
Lelland C. Tolbert, Ph.D.
OBJECTIVE: The authors goal was to determine whether sertraline attenuates the increased platelet activation seen among depressed patients.METHOD: They tested 21 otherwise healthy patients with untreated major depressive episode who were 2552 years old and 21 age- and sex-matched comparison subjects. Patients received 6 weeks of sertraline treatment, and 17 returned for retesting.RESULTS: At baseline, the depressed patients had greater platelet secretion than the comparison subjects in response to collagen. Depressed patients with a family history of coronary disease had nonsignificantly greater wound-induced fibrinogen receptor binding than the other subjects. Platelet secretion in response to collagen was significantly reduced after treatment with sertraline.CONCLUSIONS: Sertraline diminished the increased platelet secretion found among depressed patients, although the findings are limited by a lack of a placebo control group.
This article has been cited by other articles:

|
 |

|
 |
 
E. C. Bruce, Y. Guo, K. C. Lawson, A. K. Manatunga, S. F. Auyeung, W. M. McDonald, N. Rushing, A. R. Brown, N. Gilles, M. Emery, et al.
Platelet Thromboxane A2 Secretion in Patients With Major Depression Responsive to Electroconvulsive Therapy
Psychosom Med,
April 1, 2008;
70(3):
319 - 327.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. E. Von Ruden, D. E. Adson, and M. Kotlyar
Effect of Selective Serotonin Reuptake Inhibitors on Cardiovascular Morbidity and Mortality
Journal of Cardiovascular Pharmacology and Therapeutics,
March 1, 2008;
13(1):
32 - 40.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Chen, J. J Guo, H. Li, L. Wulsin, and N. C Patel
Risk of Cerebrovascular Events Associated with Antidepressant Use in Patients with Depression: A Population-Based, Nested Case-Control Study
Ann. Pharmacother.,
February 1, 2008;
42(2):
177 - 184.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. C. Ziegelstein, K. Parakh, A. Sakhuja, and U. Bhat
Depression and Coronary Artery Disease: Is There a Platelet Link?
Mayo Clin. Proc.,
November 1, 2007;
82(11):
1366 - 1368.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. A Blumenthal, A. Sherwood, S. D. Rogers, M. A. Babyak, P. Murali Doraiswamy, L. Watkins, B. M. Hoffman, C. O'Connell, J. J. Johnson, S. M. Patidar, et al.
Understanding prognostic benefits of exercise and antidepressant therapy for persons with depression and heart disease: the UPBEAT study rationale, design, and methodological issues
Clinical Trials,
October 1, 2007;
4(5):
548 - 559.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
K. J. Salaycik, M. Kelly-Hayes, A. Beiser, A.-H. Nguyen, S. M. Brady, C. S. Kase, and P. A. Wolf
Depressive Symptoms and Risk of Stroke: The Framingham Study
Stroke,
January 1, 2007;
38(1):
16 - 21.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Tiihonen, J. Lonnqvist, K. Wahlbeck, T. Klaukka, A. Tanskanen, and J. Haukka
Antidepressants and the Risk of Suicide, Attempted Suicide, and Overall Mortality in a Nationwide Cohort
Arch Gen Psychiatry,
December 1, 2006;
63(12):
1358 - 1367.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Schneiderman and R. B. Williams
THE GREAT DEBATE EDITORIAL, REVISITED
Psychosom Med,
July 1, 2006;
68(4):
636 - 638.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. H. Glassman
Does Treating Post-Myocardial Infarction Depression Reduce Medical Mortality?
Arch Gen Psychiatry,
July 1, 2005;
62(7):
711 - 712.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. B. Taylor, M. E. Youngblood, D. Catellier, R. C. Veith, R. M. Carney, M. M. Burg, P. G. Kaufmann, J. Shuster, T. Mellman, J. A. Blumenthal, et al.
Effects of Antidepressant Medication on Morbidity and Mortality in Depressed Patients After Myocardial Infarction
Arch Gen Psychiatry,
July 1, 2005;
62(7):
792 - 798.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. C. Bruce and D. L. Musselman
Depression, Alterations in Platelet Function, and Ischemic Heart Disease
Psychosom Med,
May 1, 2005;
67(Supplement_1):
S34 - S36.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. D. Taylor, D. C. Steffens, J. R. MacFall, D. R. McQuoid, M. E. Payne, J. M. Provenzale, and K. R. R. Krishnan
White Matter Hyperintensity Progression and Late-Life Depression Outcomes
Arch Gen Psychiatry,
November 1, 2003;
60(11):
1090 - 1096.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Schins, A. Honig, H. Crijns, L. Baur, and K. Hamulyak
Increased Coronary Events in Depressed Cardiovascular Patients: 5-HT2A Receptor as Missing Link?
Psychosom Med,
September 1, 2003;
65(5):
729 - 737.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. L. Serebruany, A. H. Glassman, A. I. Malinin, C. B. Nemeroff, D. L. Musselman, L. T. van Zyl, M. S. Finkel, K. R. R. Krishnan, M. Gaffney, W. Harrison, et al.
Platelet/Endothelial Biomarkers in Depressed Patients Treated With the Selective Serotonin Reuptake Inhibitor Sertraline After Acute Coronary Events: The Sertraline AntiDepressant Heart Attack Randomized Trial (SADHART) Platelet Substudy
Circulation,
August 26, 2003;
108(8):
939 - 944.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. H. Sauer, J. A. Berlin, and S. E. Kimmel
Effect of Antidepressants and Their Relative Affinity for the Serotonin Transporter on the Risk of Myocardial Infarction
Circulation,
July 8, 2003;
108(1):
32 - 36.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. E. Clouse, P. J. Lustman, K. E. Freedland, L. S. Griffith, J. B. McGill, and R. M. Carney
Depression and Coronary Heart Disease in Women With Diabetes
Psychosom Med,
May 1, 2003;
65(3):
376 - 383.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. M. Whyte, B. G. Pollock, W. R. Wagner, B. H. Mulsant, R. E. Ferrell, S. Mazumdar, and C. F. Reynolds III
Influence of Serotonin-Transporter-Linked Promoter Region Polymorphism on Platelet Activation in Geriatric Depression
Am J Psychiatry,
December 1, 2001;
158(12):
2074 - 2076.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. H. Sauer, J. A. Berlin, and S. E. Kimmel
Selective Serotonin Reuptake Inhibitors and Myocardial Infarction
Circulation,
October 16, 2001;
104(16):
1894 - 1898.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. C. Ziegelstein
Depression in Patients Recovering From a Myocardial Infarction
JAMA,
October 3, 2001;
286(13):
1621 - 1627.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Ohira, H. Iso, S. Satoh, T. Sankai, T. Tanigawa, Y. Ogawa, H. Imano, S. Sato, A. Kitamura, T. Shimamoto, et al.
Prospective Study of Depressive Symptoms and Risk of Stroke Among Japanese Editorial Comment : Is Depression a Risk Factor for Ischemic Stroke?
Stroke,
April 1, 2001;
32(4):
903 - 908.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Get information about faster international access.
a>
Privacy Policy
Copyright © 2000
American Psychiatric Association.
All rights reserved.
Home
| Search
| Current Issue
| Past Issues
| Subscribe
| All APPI Journals
| Help
| Contact Us
|